Two more monoclonals rendered ineffective by further mutations of the covid virus. Facilities are asked to preserve their supplies of Evushield in the event future mutations are found to once again become succeptible to Evushield. Evushield is a monoclonal cocktail used to treat mild to moderate covid regardless of vaccine status.
Personally, I prefer Bomazcromib extended release. Or the old standby, Hectranofib, in those big-ass capsules.